acyl coenzyme A dehydrogenase (MCAD) deficiency is the most common of the inborn errors of mitochondrial fatty acid b-oxidation. A male infant was born at 39 weeks of gestation following an uneventful pregnancy. He was discharged at age 28 h after a normal first-day check, but was subsequently re-admitted and died aged 44 h. Post-mortem blood and bile spot carnitine analysis revealed a profile consistent with MCAD deficiency. MCAD genotyping revealed 985 A to G (K329E) homozygosity. This is the first confirmed case of neonatal death due to MCAD deficiency in the UK.
Introduction
Medium-chain acyl coenzyme A dehydrogenase (MCAD) deficiency is an inherited metabolic disorder and is the most common of the inborn errors of mitochondrial fatty acid β-oxidation. Typically, manifestations are seen between 3 months and 5.1 years of age, with 13% having symptoms in the neonatal period. 1 This report details the first confirmed case of neonatal death due to MCAD deficiency in the UK.
Case report
A male infant weighing 3.2 kg at birth was born at 39 weeks of gestation to nonconsanguineous parents following an uneventful pregnancy. Birth was by ventouse extraction due to failure to progress in the second stage of labour. The infant did not require any resuscitation at birth. He was discharged 28 h after birth following a normal first day newborn check and was breast-feeding on demand.
At 35 h of age, he was unsettled and grizzly. He progressively refused feeds and became more irritable. He stopped breathing at 44 h of age. Unfortunately, in spite of adequate and prolonged resuscitation on site and in the emergency department, he died.
A post-mortem examination was performed after obtaining parental consent. The autopsy report revealed extensive lipid deposition in the liver and the renal epithelial tubules, demonstrated by Oil Red O staining. This was highly suspicious of an underlying metabolic disease. Post-mortem blood and bile spot carnitine analysis revealed a profile consistent with MCAD deficiency, and MCAD genotyping revealed 985 A to G (K329E) homozygosity.
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Discussion
Since the first description of a patient with MCAD deficiency in 1976, several case reports have been published. 2,3 Classical presentations of MCAD deficiency are related to periods of catabolic stress and include lethargy, vomiting and encephalopathy leading to seizures, apnoea, cardiac arrest and death.
The overall incidence of MCAD deficiency in England is 4.5 per 100 000. 4 Neonatal presentation of MCAD deficiency is being increasingly recognized. A recent nationwide retrospective analysis in The Netherlands showed that 13% of MCAD deficient patients had symptoms in the neonatal period. 1 Our literature search revealed only three reported confirmed cases of neonatal deaths with MCAD deficiency worldwide. 3, 5, 6 Genetic studies have shown that 985 A to G (K329E) homozygosity on chromosome 1 at position 31 is the most common defect, occurring in 80 -90% of all cases. 7 Allelic analysis of our patient also demonstrated this homozygous state. Patients with this mutation have a varied presentation, hence we put forward the suggestion as to whether some additional, unknown factor might be responsible for fatal neonatal presentation. Routine neonatal screening for MCAD deficiency is carried out along with the Guthrie test at 5 -7 days after birth. Despite this, however, MCAD deficiency in some neonates, like the one that we have reported on, will continue to be missed due to early presentation.
